Events & Presentations Latest Presentation Corporate Presentation - Upcoming Events There are no upcoming events available at this time. Past Events May 11, 2022 at 4:40 PM PDT Bank of America 2022 Healthcare Conference Click here for webcast Apr 7, 2022 at 8:00 AM EDT Vectiv Bio Full Year 2021 Financial Results and Company Update Click here for webcast Feb 17, 2022 at 1:40 PM EST 2022 SVB Leerink Global Healthcare Conference Click here for webcast Nov 11, 2021 at 9:40 AM EST Credit Suisse 30th Annual Healthcare Conference Click here for webcast Sep 23, 2021 SVB Leerink CybeRX Series: Neuromuscular, Rare Diseases & Genetic Medicines 1x1 Event Sep 21, 2021 at 10:00 AM EDT VectivBio R&D Day Click here for webcast R&D Day presentation 3.5 MB Sep 2, 2021 at 8:00 AM EDT Extraordinary General Meeting Minutes 149.1 KB Scientific Publications A Phase 1, Open-Label Evaluation of the Pharmacokinetics and Safety of a Single Dose of Apraglutide in Subjects with Normal and Impaired Renal Function: 2022 American Society for Parenteral and Enteral Nutrition. Seattle, Washington March 29, 2022 Apraglutide Does Not Impact Anti-tumor and Immunosuppressive Efficacy of Conditioning Chemotherapy in Mice Presentation Location: The European Society for Blood and Bone Marrow Transplantation (EMBT) Annual Meeting 2022. Prague, Czech Republic March 23, 2022 Apraglutide Decreases Severity of Intestinal Damage from Gastrointestinal (GI) Acute Graft Versus Host Disease(GvHD) Following Allogeneic Transplantation Without Impacting Engraftment Presentation Location: The European Society for Blood and Bone Marrow T March 22, 2022 Apraglutide Treatment Reduces Chemotherapy-Induced Gastrointestinal (GI) Damage in Mice and Preserves Cellular Integrity During Chemotherapy Presentation Location: The European Society for Blood and Bone Marrow Transplantation (EMBT) Annual Meeting 2022. March 22, 2022 Treatment with Apraglutide Preserves the Global Homeostatic Environment of Intestinal Microbiota During Chemotherapy in Mice Presentation Location: The European Society for Blood and Bone Marrow Transplantation (EMBT) Annual Meeting 2022. Prague, Czech Re March 22, 2022
Latest Presentation Corporate Presentation - Upcoming Events There are no upcoming events available at this time. Past Events May 11, 2022 at 4:40 PM PDT Bank of America 2022 Healthcare Conference Click here for webcast Apr 7, 2022 at 8:00 AM EDT Vectiv Bio Full Year 2021 Financial Results and Company Update Click here for webcast Feb 17, 2022 at 1:40 PM EST 2022 SVB Leerink Global Healthcare Conference Click here for webcast Nov 11, 2021 at 9:40 AM EST Credit Suisse 30th Annual Healthcare Conference Click here for webcast Sep 23, 2021 SVB Leerink CybeRX Series: Neuromuscular, Rare Diseases & Genetic Medicines 1x1 Event Sep 21, 2021 at 10:00 AM EDT VectivBio R&D Day Click here for webcast R&D Day presentation 3.5 MB Sep 2, 2021 at 8:00 AM EDT Extraordinary General Meeting Minutes 149.1 KB Scientific Publications A Phase 1, Open-Label Evaluation of the Pharmacokinetics and Safety of a Single Dose of Apraglutide in Subjects with Normal and Impaired Renal Function: 2022 American Society for Parenteral and Enteral Nutrition. Seattle, Washington March 29, 2022 Apraglutide Does Not Impact Anti-tumor and Immunosuppressive Efficacy of Conditioning Chemotherapy in Mice Presentation Location: The European Society for Blood and Bone Marrow Transplantation (EMBT) Annual Meeting 2022. Prague, Czech Republic March 23, 2022 Apraglutide Decreases Severity of Intestinal Damage from Gastrointestinal (GI) Acute Graft Versus Host Disease(GvHD) Following Allogeneic Transplantation Without Impacting Engraftment Presentation Location: The European Society for Blood and Bone Marrow T March 22, 2022 Apraglutide Treatment Reduces Chemotherapy-Induced Gastrointestinal (GI) Damage in Mice and Preserves Cellular Integrity During Chemotherapy Presentation Location: The European Society for Blood and Bone Marrow Transplantation (EMBT) Annual Meeting 2022. March 22, 2022 Treatment with Apraglutide Preserves the Global Homeostatic Environment of Intestinal Microbiota During Chemotherapy in Mice Presentation Location: The European Society for Blood and Bone Marrow Transplantation (EMBT) Annual Meeting 2022. Prague, Czech Re March 22, 2022
A Phase 1, Open-Label Evaluation of the Pharmacokinetics and Safety of a Single Dose of Apraglutide in Subjects with Normal and Impaired Renal Function: 2022 American Society for Parenteral and Enteral Nutrition. Seattle, Washington March 29, 2022
Apraglutide Does Not Impact Anti-tumor and Immunosuppressive Efficacy of Conditioning Chemotherapy in Mice Presentation Location: The European Society for Blood and Bone Marrow Transplantation (EMBT) Annual Meeting 2022. Prague, Czech Republic March 23, 2022
Apraglutide Decreases Severity of Intestinal Damage from Gastrointestinal (GI) Acute Graft Versus Host Disease(GvHD) Following Allogeneic Transplantation Without Impacting Engraftment Presentation Location: The European Society for Blood and Bone Marrow T March 22, 2022
Apraglutide Treatment Reduces Chemotherapy-Induced Gastrointestinal (GI) Damage in Mice and Preserves Cellular Integrity During Chemotherapy Presentation Location: The European Society for Blood and Bone Marrow Transplantation (EMBT) Annual Meeting 2022. March 22, 2022
Treatment with Apraglutide Preserves the Global Homeostatic Environment of Intestinal Microbiota During Chemotherapy in Mice Presentation Location: The European Society for Blood and Bone Marrow Transplantation (EMBT) Annual Meeting 2022. Prague, Czech Re March 22, 2022